Company Directory / Biotechnology

Public · NASDAQ:INSMFor profitBiotechnologyBridgewater Township, New Jersey, United States
Insmed is a biopharmaceutical company creating medicine for rare diseases.
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and… Read all
Insmed is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases. We are dedicated to making a meaningful impact in patients’ lives as well as the communities where we live and work. Our team is guided by our core values of collaboration, accountability, passion, respect, and integrity. Insmed is headquartered in Bridgewater, NJ, and has offices and research locations throughout the United States, Europe, and Japan. We are proud to be recognized as one of the best employers in the biopharmaceutical industry, including spending four consecutive years as the No. 1 Science Top Employer. Join the Insmed team to accelerate your career and help make every moment and every patient count. Community guidelines: http://bit.ly/3DbEjVG
Size
501-1000 people: larger than 95% of companies with a size listed. 1,411 people list it on LinkedIn.
Age
38 years old.
Reach
Website ranked #505,411 in the world for traffic, about 67k visits a month. 50,890 followers on LinkedIn.
BiotechnologyMedicalPharmaceuticalBiotechnologyOrphan Disease StatePharmaceuticalsChronic Lung InfectionsPulmonary
Funding, as listed
$3.8B raised in total
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Everything the source datasets list about Insmed, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
Corporate family
About this record
Growth, as the source summarises it
Insmed's first quarter 2024 earnings report showed that while the company's EPS beat expectations, its revenues lagged behind. Additionally, the full year 2023 earnings report indicated that Insmed's EPS missed expectations.
Summaries written by the source dataset, not by us, and not checked.
Biotechnology in United States.
InvitaeSan Francisco · 1001-5000 people · 146k followers
Amicus TherapeuticsPrinceton · 501-1000 people · 48k followers
GrailMenlo Park · 1001-5000 people
PacBioMenlo Park · 501-1000 people · 85k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.